News
MHRA grants marketing authorisation for Global Blood Therapeutics’s Oxbryta
Global Blood Therapeutics (GBT) has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted Britain marketing authorisation for Oxbryta – also known as voxelotor.